The Ohio State University — Columbus, Ohio

Public research footprint of The Ohio State University, compiled from the ClinicalTrials.gov public registry.

1,959

Registered studies

615

Active

330

Recruiting now

961

Completed

319

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia · PDAC - Pancreatic Ductal Adenocarcinoma · Non-muscle Invasive Bladder Cancer (NMIBC) · SLL (Small Lymphocytic Lymphoma)

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT06624670 — A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma… (Recruiting)
NCT06678841 — ELEVATE-HFpEF Clinical Study (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Ohio State University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.